skip to content

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase Ib results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity

Media

Media releases
view all

stay updated

get the latest news and updates to your inbox.